Stewart F M, Crittenden R B, Lowry P A, Pearson-White S, Quesenberry P J
Department of Medicine, University of Virginia Health Sciences Center, Charlottesville.
Blood. 1993 May 15;81(10):2566-71.
We report the successful long-term engraftment of normal male donor bone marrow (BM) transfused into noncytoablated female mice, challenging the assumption that "niches" need to be created for marrow to engraft. We have used chromosomal banding and Southern blot analysis to identify transplanted male marrow cells, and shown the long-term stability of the chimeric marrows. Balb/C, BDF1, or CBA-J female hosts (no irradiation) received for 5 consecutive days 40 x 10(6) male cells (per day) of the same strain, and repopulation patterns were observed. Parallel studies were performed using tibia/femur equivalents of normal marrow or marrow from Balb/C mice pretreated 6 days previously with 150 mg/kg 5-fluorouracil (5-FU). Chromosome banding techniques showed that 5% to 46% of marrow cells were male 3 to 9 months posttransplant with normal donor marrow. Southern blot analysis, using the pY2 probe, showed continued engraftment at 21 to 25 months posttransplant, ranging from 15% to 42% male engrafted cells in marrow. Normal donor male marrow engrafted significantly better than 5-FU-pretreated male marrow as shown 1 to 12 months posttransplant in non-cytoablated female recipients. Percentages of male engrafted cells in BM ranged from 23% to 78% for recipients of normal donor marrow and from 0.1% to 39% for recipients of 5-FU marrow. Mean engraftment for 6 mice receiving normal marrow was 38%, whereas that for 6 mice receiving post-5-FU marrow was 8%, as assayed 1 to 3 months posttransplant. At 10 to 12 months, mean engraftment for the normal donor group was 46%, compared with 16% for the 5-FU group. The patterns of engraftment with normal and 5-FU marrow were similar for spleen and thymus. These results show that long-term chimerism can be established after transplantation of normal donor marrow to normal nonirradiated host mice and indicate that marrow spaces do not have to be created for successful engraftment. They suggest that transplanted marrow competes equally with host marrow for marrow space. Finally, these data show that post-5-FU Balb/C male marrow is markedly inferior in the repopulation of Balb/C female host marrow, spleen, and thymus, and suggest that this population of cells may not be the ideal population for gene transfer studies.
我们报告了将正常雄性供体骨髓(BM)输注到未进行细胞清除的雌性小鼠体内并成功实现长期植入的案例,这对“需要为骨髓植入创造‘龛位’”这一假设提出了挑战。我们使用染色体显带和Southern印迹分析来鉴定移植的雄性骨髓细胞,并展示了嵌合骨髓的长期稳定性。Balb/C、BDF1或CBA-J雌性宿主(未接受照射)连续5天每天接受40×10⁶个同品系的雄性细胞,并观察其再填充模式。使用正常骨髓或6天前用150mg/kg 5-氟尿嘧啶(5-FU)预处理的Balb/C小鼠的骨髓的胫骨/股骨等效物进行了平行研究。染色体显带技术显示,移植正常供体骨髓后3至9个月,5%至46%的骨髓细胞为雄性。使用pY2探针的Southern印迹分析显示,移植后21至25个月仍持续植入,骨髓中雄性植入细胞的比例为15%至42%。在未进行细胞清除的雌性受体中,移植后1至12个月显示,正常供体雄性骨髓的植入明显优于5-FU预处理的雄性骨髓。正常供体骨髓受体的骨髓中雄性植入细胞的百分比为23%至78%,5-FU骨髓受体的为0.1%至39%。移植后1至3个月检测,接受正常骨髓的6只小鼠的平均植入率为38%,而接受5-FU处理后骨髓的6只小鼠为8%。在10至12个月时,正常供体组的平均植入率为46%,而5-FU组为16%。脾脏和胸腺中正常骨髓和5-FU骨髓的植入模式相似。这些结果表明,将正常供体骨髓移植到正常未照射的宿主小鼠后可建立长期嵌合状态,并表明无需为成功植入创造骨髓空间。它们表明移植的骨髓与宿主骨髓在骨髓空间竞争中具有同等竞争力。最后,这些数据显示,5-FU处理后的Balb/C雄性骨髓在Balb/C雌性宿主骨髓、脾脏和胸腺的再填充方面明显较差,并表明这群细胞可能不是基因转移研究的理想细胞群。